Haddad P. Newer antidepressants and the discontinuation syndrome. J Clin Psychiatry. 1997;58:17–21.
Horowitz M, Taylor D. How do we determine whether antidepressants are useful or not? Lancet Psychiatry. 2019;6:888.
Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav. 2019;97:111–21.
Price JS, Waller PC, Wood SM, MacKay AV. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol. 1996;42:757–63.
Article CAS PubMed PubMed Central Google Scholar
Gastaldon C, Schoretsanitis G, Arzenton E, Raschi E, Papola D, Ostuzzi G, et al. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database. Drug Safety. 2022;45:1539–49.
Article CAS PubMed PubMed Central Google Scholar
Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom. 2015;84:72–81.
Bosker FJ, Tanke MA, Jongsma ME, Cremers TI, Jagtman E, Pietersen CY, et al. Biochemical and behavioral effects of long-term citalopram administration and discontinuation in rats: role of serotonin synthesis. Neurochem Int. 2010;57:948–57.
Article CAS PubMed Google Scholar
Collins HM, Pinacho R, Ozdemir D, Bannerman DM, Sharp T. Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice. J Psychopharmacol. 2022;36:794–805.
Article CAS PubMed PubMed Central Google Scholar
Handley SL, McBlane JW. Serotonin mechanisms in animal models of anxiety. Braz J Med Biol Res. 1993;26:1–13.
Sharp T. Molecular and cellular mechanisms of antidepressant action. Curr Top Behav Neurosci. 2013;14:309–25.
Article CAS PubMed Google Scholar
Blier P, Tremblay P. Physiologic mechanisms underlying the antidepressant discontinuation syndrome. J Clin Psychiatry. 2006;67:8–13.
Harvey BH, Slabbert FN. New insights on the antidepressant discontinuation syndrome. Hum Psychopharmacol. 2014;29:503–16.
Article CAS PubMed Google Scholar
Renoir T. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved. Front Pharmacol. 2013;4:45.
Article PubMed PubMed Central Google Scholar
Trouvin JH, Gardier AM, Chanut E, Pages N, Jacquot C. Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat. Life Sci. 1993;52:PL187–92.
Article CAS PubMed Google Scholar
Stenfors C, Ross SB. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life Sci. 2002;71:2867–80.
Article CAS PubMed Google Scholar
Fuller RW, Perry KW, Molloy BB. Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci. 1974;15:1161–71.
Article CAS PubMed Google Scholar
Ogren SO, Ross SB, Hall H, Holm AC, Renyi AL. The pharmacology of zimelidine: a 5-HT selective reuptake inhibitor. Acta Psychiatr Scand Suppl. 1981;290:127–51.
Article CAS PubMed Google Scholar
Barton CL, Hutson PH. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Synapse. 1999;31:13–19.
Article CAS PubMed Google Scholar
Kuhn DM, Wolf WA, Youdim MB. Serotonin neurochemistry revisited: A new look at some old axioms. Neurochem Int. 1986;8:141–54.
Article CAS PubMed Google Scholar
Sharp T, Bramwell SR, Clark D, Grahame-Smith DG. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J Neurochem. 1989;53:234–40.
Article CAS PubMed Google Scholar
Rogawski MA. Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr. 2005;5:225–30.
Article PubMed PubMed Central Google Scholar
Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020;395:1938–48.
Article CAS PubMed PubMed Central Google Scholar
Lerner A, Klein M. Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. Brain Commun. 2019;1:fcz025.
Article PubMed PubMed Central Google Scholar
Warlick H, Leon L, Patel R, Filoramo S, Knipe R, Joubran E, et al. Application of gabapentinoids and novel compounds for the treatment of benzodiazepine dependence: the glutamatergic model. Mol Biol Rep. 2023;50:1765–84.
Antoniadou I, Kouskou M, Arsiwala T, Singh N, Vasudevan SR, Fowler T, et al. Ebselen has lithium-like effects on central 5-HT(2A) receptor function. Br J Pharmacol. 2018;175:2599–610.
Article CAS PubMed PubMed Central Google Scholar
Franklin, KBJ, Paxinos, G. The Mouse Brain in Stereotaxic Coordinates. Academic Press, (1997).
Radford-Smith DE, Probert F, Burnet P, Anthony DC. Modifying the maternal microbiota alters the gut-brain metabolome and prevents emotional dysfunction in the adult offspring of obese dams. Proc Natl Acad Sci USA. 2022;119:e2108581119.
Article CAS PubMed PubMed Central Google Scholar
Gorlova A, Ortega G, Waider J, Bazhenova N, Veniaminova E, Proshin A, et al. Stress-induced aggression in heterozygous TPH2 mutant mice is associated with alterations in serotonin turnover and expression of 5-HT6 and AMPA subunit 2A receptors. J Affect Disord. 2020;272:440–51.
Article CAS PubMed Google Scholar
Guilloux JP, David DJ, Xia L, Nguyen HT, Rainer Q, Guiard BP, et al. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology. 2011;61:478–88.
Article CAS PubMed Google Scholar
Couch Y, Xie Q, Lundberg L, Sharp T, Anthony DC. A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice. PLoS One. 2015;10:e0130643.
Article PubMed PubMed Central Google Scholar
Vogelgesang S, Niebert S, Renner U, Möbius W, Hülsmann S, Manzke T, et al. Analysis of the Serotonergic System in a Mouse Model of Rett Syndrome Reveals Unusual Upregulation of Serotonin Receptor 5b. Front Mol Neurosci. 2017;10:61.
Article PubMed PubMed Central Google Scholar
Yu Z, Lin D, Zhong Y, Luo B, Liu S, Fei E, et al. Transmembrane protein 108 involves in adult neurogenesis in the hippocampal dentate gyrus. Cell Biosci. 2019;9:9.
Article PubMed PubMed Central Google Scholar
Sharp T, Boothman L, Raley J, Quérée P. Important messages in the ‘post’: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci. 2007;28:629–36.
Article CAS PubMed Google Scholar
Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, et al. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses. Eur J Pharmacol. 1998;347:41–9.
Article CAS PubMed Google Scholar
Ohmura Y, Tsutsui-Kimura I, Sasamori H, Nebuka M, Nishitani N, Tanaka KF, et al. Different roles of distinct serotonergic pathways in anxiety-like behavior, antidepressant-like, and anti-impulsive effects. Neuropharmacology. 2020;167:107703.
Article CAS PubMed Google Scholar
Kreilgaard M, Smith DG, Brennum LT, Sánchez C. Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol. 2008;155:276–84.
Article CAS PubMed PubMed Central Google Scholar
Bourin M, Chue P, Guillon Y. Paroxetine: a review. CNS Drug Rev. 2001;7:25–47.
Comments (0)